294 related articles for article (PubMed ID: 22892126)
21. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Lim AK; Ma FY; Nikolic-Paterson DJ; Ozols E; Young MJ; Bennett BL; Friedman GC; Tesch GH
Am J Nephrol; 2011; 34(4):337-46. PubMed ID: 21876346
[TBL] [Abstract][Full Text] [Related]
22. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
[TBL] [Abstract][Full Text] [Related]
23. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
Kim BH; Lee ES; Choi R; Nawaboot J; Lee MY; Lee EY; Kim HS; Chung CH
Yonsei Med J; 2016 May; 57(3):664-73. PubMed ID: 26996567
[TBL] [Abstract][Full Text] [Related]
24. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.
Sung SH; Ziyadeh FN; Wang A; Pyagay PE; Kanwar YS; Chen S
J Am Soc Nephrol; 2006 Nov; 17(11):3093-104. PubMed ID: 16988063
[TBL] [Abstract][Full Text] [Related]
25. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
[TBL] [Abstract][Full Text] [Related]
26. Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes.
Choi R; Kim BH; Naowaboot J; Lee MY; Hyun MR; Cho EJ; Lee ES; Lee EY; Yang YC; Chung CH
Exp Mol Med; 2011 Dec; 43(12):676-83. PubMed ID: 21975281
[TBL] [Abstract][Full Text] [Related]
27. Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin.
Zhang Y; Fukusumi Y; Kayaba M; Nakamura T; Sakamoto R; Ashizawa N; Kawachi H
Nefrologia (Engl Ed); 2021; 41(5):539-547. PubMed ID: 36165136
[TBL] [Abstract][Full Text] [Related]
28. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
[TBL] [Abstract][Full Text] [Related]
30. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
[TBL] [Abstract][Full Text] [Related]
31. Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats.
Fujita A; Sasaki H; Doi A; Okamoto K; Matsuno S; Furuta H; Nishi M; Nakao T; Tsuno T; Taniguchi H; Nanjo K
Diabetes Res Clin Pract; 2008 Jan; 79(1):11-7. PubMed ID: 17897750
[TBL] [Abstract][Full Text] [Related]
32. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
33. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
[TBL] [Abstract][Full Text] [Related]
35. The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats.
Song Z; Guo Y; Zhou M; Zhang X
Metabolism; 2014 Oct; 63(10):1324-33. PubMed ID: 25044177
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.
Benigni A; Zoja C; Tomasoni S; Campana M; Corna D; Zanchi C; Gagliardini E; Garofano E; Rottoli D; Ito T; Remuzzi G
J Am Soc Nephrol; 2006 Jun; 17(6):1624-32. PubMed ID: 16687628
[TBL] [Abstract][Full Text] [Related]
37. FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats.
Qi XM; Wang J; Xu XX; Li YY; Wu YG
Inflamm Res; 2016 Feb; 65(2):103-14. PubMed ID: 26566632
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
39. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
40. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
